低血管生成:可能是干老性黄斑退化发展的病理因素,也是新的治疗点
1Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences Sciences (AIIMS), New Delhi, India.
Medical hypothesis, discovery & innovation ophthalmology journal
|August 29, 2023
概括
干燥的与年龄相关的黄斑变性 (AMD) 可能源于血管内皮生长因子 (VEGF) 合成的减少,与湿的AMD不同,它涉及VEGF上调. 这表明干性AMD的潜在治疗性血管生成.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 再生医学是一种再生医学.
背景情况:
- 排泄性 (湿) 与年龄有关的黄斑变性 (AMD) 涉及血管内皮生长因子 (VEGF) 的上调,导致视力丧失.
- 驱动干燥AMD和视网膜色素表皮 (RPE) 细胞损失的分子机制在很大程度上是未知的.
- 维EGF对于胆囊细胞发育和RPE存活至关重要,其缺少会导致RPE特异性缺陷.
研究的目的:
- 调查假设减少VEGF合成 (低血管生成) 或VEGFR异常有助于干燥AMD的发病.
- 探索治疗性血管生成作为干性AMD治疗策略的潜力.
主要方法:
- 该研究建议通过实验研究探索减少VEGF分泌和/或增加受体抵抗/异常.
- 调查VEGF及其受体在RPE存活率和choriocapillaris完整性中的作用.
主要成果:
- 建议进行实验性研究,以探索减少VEGF和干燥AMD之间的联系.
- 研究结果表明,低血管生成可能是干性AMD发展的关键因素.
结论:
- 干性AMD可能是VEGF合成减少的结果,导致RPE细胞存活率降低.
- 准VEGF通路或诱导血管生成可能是干性AMD的潜在治疗策略.
- 需要进一步的实验研究来验证这些假设,并为临床试验提供信息.
关键词:
在VEGF中,VEGF是VEGF.一个自由的接受.与年龄相关的黄斑变性.血管新生是因为血管新生.这是一种反-VEGF的药物.这是bevacizumab的治疗方法.这就是brolucizumab.干燥的 AMD 干燥的 AMD排泄性AMD是一种AMD.地理缩是地理上的缩.血管新生缺陷的产生.斑点退化症 斑点退化症拉尼比祖马布拉尼尼比祖马布拉尼治疗性血管生成治疗性血管生成血管内皮生长因子 血管内皮生长因子湿斑变性 湿斑变性 湿斑变性更多相关视频
06:51Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
Published on: December 9, 2022
4.2K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.1K
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
01:10Mechanism of Angiogenesis
5.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K